Unità di Riabilitazione Neuromotoria, Unità Gravi Cerebrolesioni Acquisite, Fondazione S. Maugeri, IRCCS, Istituto Scientifico di Montescano, Montescano, Pavia, Italy
Nutr Clin Pract. 2012 Feb;27(1):99-113. doi: 10.1177/0884533611431068.
To investigate whether supplementation with oral essential amino acids (EAAs) may reduce the occurrence of nosocomial infection among patients with brain injury (BI: stroke, trauma, anoxic coma).
Patients (n = 125; 77 men, 48 women; mean age 63 ± 15 years) with stroke (68.8%), subarachnoid hemorrhage (17.6%), traumatic BI (7.2%), and anoxic BI (6.4%) 88 ± 15 days after the index event. Patients were randomly assigned to 2 months of oral EAAs (n = 63; 8 g/d) or placebo (n = 62).
Over the first month of rehabilitation, there were 60 infections in the whole population of 125 patients (48%); however, the rate was 23.2% lower in the EAA group (23 episodes/63 patients; 36.5%) than in the placebo group (37 episodes/62 patients; 59.7%) (P < .01). The types of infection were similarly distributed between the 2 groups. Serum levels of prealbumin <20 mg/dL and C-reactive protein (CRP) >0.3 mg/dL were the best predictors of future infection (prealbumin: odds ratio [OR] = 4.17, confidence interval [CI] 1.84-9.45, P < .001; CRP: OR = 3.8, CI 1.71-8.44, P < .001).
Supplementary EAAs may reduce the occurrence of nosocomial infections in rehabilitation patients with BI. Prealbumin and CRP are the best predictors of future infections.
为了研究口服必需氨基酸(EAA)补充是否可以降低脑损伤(BI:中风、创伤、缺氧性昏迷)患者的医院感染发生率。
125 名患者(63 名男性,62 名女性;平均年龄 63±15 岁),分别患有中风(68.8%)、蛛网膜下腔出血(17.6%)、创伤性 BI(7.2%)和缺氧性 BI(6.4%),于首发事件后 88±15 天入组。患者被随机分配接受 2 个月的口服 EAA(n=63;8g/d)或安慰剂(n=62)治疗。
在康复治疗的第一个月,125 例患者中共有 60 例(48%)发生感染;然而,EAA 组的感染率(23 例/63 例;36.5%)比安慰剂组(37 例/62 例;59.7%)低 23.2%(P<.01)。两组的感染类型分布相似。血清前白蛋白<20mg/dL 和 C 反应蛋白(CRP)>0.3mg/dL 是未来感染的最佳预测指标(前白蛋白:比值比[OR]4.17,95%置信区间[CI]1.84-9.45,P<.001;CRP:OR=3.8,CI 1.71-8.44,P<.001)。
EAA 补充可能会降低 BI 康复患者的医院感染发生率。前白蛋白和 CRP 是未来感染的最佳预测指标。